Clinical Trial Results:
A prospective multicentre phase II trial of zoledronic acid in patients with myelofibrosis with myeloid metaplasia (MMM)
Summary
|
|
EudraCT number |
2005-003985-40 |
Trial protocol |
BE ES DE FR |
Global completion date |
28 Nov 2008
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
30 Oct 2020
|
First version publication date |
30 Oct 2020
|
Other versions |
|
Summary report(s) |
Lack of clinical benefit of zoledronic acid in myelofibrosis: results of a prospective multi-center phase II trial |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.